Lisa Spalding

Harry Perkins Institute of Medical Research

H指数:8

被引数:289

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Exploring Traditional Breast Cancer Risk Genes Among Aboriginal and Torres Strait Islander Women

探索土著和托雷斯海峡岛民女性中的传统乳腺癌风险基因

Life-Basel

IF3.4

2026-08-300

Inhibition of the Caveolin-1 pathway promotes apoptosis and overcomes pan-tyrosine kinase inhibitor resistance in hepatocellular carcinoma

抑制 Caveolin-1 通路促进凋亡并克服泛酪氨酸激酶抑制剂耐药性在肝细胞癌中

Cell Death & Disease

IF9.6

2025-07-250

OAAI

The anti-metastatic role of BMP4 through cholesterol biosynthesis inhibition and consequent interaction with statin benefit in breast cancer

CANCER RESEARCH

IF16.6

2024-05-020

PRE

Obesity May Modulate the Relationship Between High Mammographic Breast Density and Neoadjuvant Chemoresistance in Early Breast Cancer

CANCER RESEARCH

IF16.6

2024-05-020

PRE

Locoregional Management Based on Mode of Progression for HR+/HER2-metastatic breast cancer Treated with Combined CDK4/6 inhibitor with Aromatase inhibitor

CANCER RESEARCH

IF16.6

2024-05-020

PRE

The SUB-urothelial DUrvalumab InjEction-1 (SUBDUE-1) trial: first-in-human trial in patients with bladder cancer

上皮下注射DUrvalumab-1 (SUBDUE-1) 试验: 膀胱癌患者的首次人体试验

BJU INTERNATIONAL

IF4.4

2024-03-121

Estrogen receptor beta expression in triple negative breast cancers is not associated with recurrence or survival

三阴性乳腺癌中雌激素受体 β 表达与复发或生存无关

BMC CANCER

IF3.4

2023-05-195

OAAI

Nuclear envelope Expression of the Oncogene Adipocyte-Associated Methionine Domain Containing Conveys Inferior Prognosis but Increased Sensitivity to Statins and Fluorouracil-Based Therapy

CANCER RESEARCH

IF16.6

2023-03-010

PRE

Adipocyte associated methionine domain containing (AAMDC): A nuclear envelope protein with predictive and prognostic potential in luminal breast cancer

CANCER RESEARCH

IF16.6

2022-02-150

PRE

Aromatase inhibitor and cyclin-dependent kinase 4/6 inhibitor treated HR+/HER2-metastatic breast cancer differ to those treated with Aromatase inhibitors alone on progression

ANNALS OF ONCOLOGY

IF65.4

2020-11-010

OAAI

The impact of site of metastasis on overall survival in indigenous and non-indigenous patients of Western Australia with breast cancer

转移部位对西澳大利亚州土著和非土著乳腺癌患者总生存期的影响

ANNALS OF ONCOLOGY

IF65.4

2020-11-010

OAAI

The influence of diabetes mellitus and diabetic management on breast cancer outcomes in indigenous women of Western Australia

糖尿病和糖尿病管理对西澳大利亚州土著妇女乳腺癌结局的影响

ANNALS OF ONCOLOGY

IF65.4

2020-09-010

OAAI

Defining pathway: A novel analysis of geriatric indigenous women with breast cancer impacting survival and outcomes

ANNALS OF ONCOLOGY

IF65.4

2020-09-010

OAAI

Survival outcome of indigenous and non-indigenous women of Western Australia with breast cancer in relation to remoteness

西澳大利亚州患有乳腺癌的土著和非土著妇女的生存结果与偏远有关

ANNALS OF ONCOLOGY

IF65.4

2020-05-010

OAAI

Breast cancer treatment patterns and outcomes for Australian women by indigenous status and remoteness of residence

CANCER RESEARCH

IF16.6

2020-02-151

PRE

Aggressive tumour biology contributes to poor breast cancer outcomes for indigenous Australians

CANCER RESEARCH

IF16.6

2020-02-150

PRE

Unfavourable tumour stromal immune cell infiltrates but not circulating immune cell profiles in Aboriginal women with breast cancer

CANCER RESEARCH

IF16.6

2020-02-150

PRE

The Kraken Wakes: induced EMT as a driver of tumour aggression and poor outcome

CLINICAL & EXPERIMENTAL METASTASIS

IF3.2

2018-06-0842

PREAI

Stromal Caveolin-1 Is a Powerful Marker That Further Enhances a Multi-Marker Prognostic Profile

CANCER RESEARCH

IF16.6

2010-12-011

PRE

Nonredundant functions for tumor protein D52-like proteins support specific targeting of TPD52

CLINICAL CANCER RESEARCH

IF10.2

2008-08-1256

OAAI

Lisa Spalding

个人简介

教育背景

工作经历

荣誉奖项

研究方向